UK Baby Undergoes Pioneering Fetal Surgery in US for Congenital Condition
A pregnant woman from London, Maisie Savage, underwent a groundbreaking surgery in the United States to correct a congenital defect in her unborn son, Theo. Savage, 29, was 26 weeks pregnant when the procedure took place. Theo was diagnosed with gastroschisis, a condition where the abdominal wall does not close completely, causing the intestines to develop outside the body. This minimally invasive surgery, performed in Houston, Texas, involved partially exposing the mother's uterus to reposition the baby's organs within his abdomen. Theo is the third baby globally to participate in this pioneering clinical study and the first British infant to undergo such an operation for complex gastroschisis. His parents, Savage and Josh French, 36, who are both teachers, were initially unaware of the condition until a 20-week scan. The diagnosis of complex gastroschisis came as a shock, prompting specialists from London's Great Ormond Street Hospital to refer them to the Texas Children's Hospital. There, a team led by Dr. Michael Belfort, who had previously pioneered similar fetal surgery for spina bifida, was conducting the world's first clinical trial for this specific condition. The process involved an initial Botox injection in Belgium to relax Theo's abdominal muscles before the main surgery in Texas. After the procedure, Theo remained in utero until his birth in February in Texas. Savage experienced a difficult recovery from the surgery, which left her with a scar larger than a Cesarean section, but considers it worthwhile. Dr. Belfort expressed satisfaction with the outcomes, noting the absence of complications. The study aims to eventually offer this treatment in the UK, with Professor Paolo de Coppi of Great Ormond Street Hospital involved in future plans. Dr. Belfort envisions expanding fetal surgery to other areas, such as cardiac and pulmonary procedures. The family has since returned to London, with Theo now five months old and thriving, described by his mother as essentially a normal baby.
This case highlights the accelerating frontier of fetal medicine, where surgical interventions are increasingly shifting from post-natal correction to pre-natal repair. The development of such complex procedures, as demonstrated by the gastroschisis correction, addresses significant unmet needs for conditions with historically poor prognoses, including high mortality rates and prolonged neonatal intensive care. The collaborative international effort underscores the global nature of medical innovation, pooling expertise and resources across institutions like the Great Ormond Street Hospital and Texas Children's Hospital. As this field advances, questions regarding equitable access, long-term outcomes for both mother and child, and the ethical considerations of intervening in utero will become paramount. The potential for future fetal surgeries in areas like cardiac and pulmonary development suggests a paradigm shift in pediatric care, moving towards proactive, in-utero management of congenital anomalies.
AI-generated to prompt reflection — not editorial opinion, not advice, not a statement of fact. How this works.
